English (international)
Eesti
Български
Deutsch
Français
Español (Latinoamérica)
Polski
Magyar
Română
Lonza Group AG
Cerrado
552 -0.29
Resumen
Variación precio
24h
Mínimo
551.4
Máximo
556
Ingresos | 244M |
|---|---|
Ventas | -582M 3.1B |
P/B Media del Sector | 26.67 |
BPA | 4.61 |
Margen de beneficio | 6.705 |
Capitalización de Mercado | -144M 40B |
|---|---|
Apertura anterior | 552.29 |
Cierre anterior | 552 |
Noticias sobre sentimiento de mercado
By Acuity
100%
0%
Lonza Group AG Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Lonza Group AG Esperado
Sentimiento
By Acuity
Noticias sobre sentimiento de mercado
Coyuntura bajista notoria
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por encima de la media
Finanzas
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Lonza Group AG
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.